I saw it was listed on HPTIs it possible to get liraglutide from grey vendors. I know its not nearly as effective from a results standpoint, but just curious.
Ah, I misinterpreted OP as saying gray lira is worse! And was surprised 🙂liraglutide is only 5-8 % weightloss, so much less effective for that.
Also, effect on appetite varies during the day because of the short halflife.
but it's not a bad drug, it does work.
Labcat, your user name says it, but I always misinterpret your pic. lol.Ah, I misinterpreted OP as saying gray lira is worse! And was surprised 🙂
Yes, that is my extra long orange tabby looking extra extra long stretched out on the couch, looking out the window.Labcat, your user name says it, but I always misinterpret your pic. lol.
Yes I have presbyopia. But I'm still not sure if it IS a cat or ??
That's a cute one !Yes, that is my extra long orange tabby looking extra extra long stretched out on the couch, looking out the window.
Now I’m a little afraid to ask… but no pain no gain… what does it look like 🤣?
🤣That's a cute one !
I'm not sure, it's a bit of a blur, but my thoughts weren't entirely pure, I have to admit. lol
First time I saw it, had to zoom in to make sure it was a lab cat lol
Well, he is more of a lap cat.First time I saw it, had to zoom in to make sure it was a lab cat lol
Phase 3 trials of liraglutide (the SCALE trial4) and semaglutide (the STEP 1 trial5) showed significant weight reduction at 56 weeks and 68 weeks, respectively, with a mean reduction of 9.2% with liraglutide and 16.9% with semaglutide. This phase 2 trial of orforglipron showed weight reduction ranging from 8.6% to 12.6% at 26 weeks and ranging from 9.4% to 14.7% at 36 weeks.
Google Gemini said:
Medication Phase Duration Mean Weight Loss Approx. Plateau Point Liraglutide Phase 3 56 Weeks ~8.0% – 9.2% ~28–32 Weeks Semaglutide Phase 3 68 Weeks ~14.9% – 16.9% ~60–68 Weeks Orforglipron Phase 3 72 Weeks ~12.4% – 14.7% ~60+ Weeks Tirzepatide Phase 3 72 Weeks ~20.9% – 22.5% ~72 Weeks Retatrutide Phase 2 48 Weeks ~24.2% Not yet reached
Google Gemini said:Lira is primarily used now as a "bridge" or for maintenance. Because it is a daily injection with a shorter half-life, it is much easier for doctors to "fine-tune" the dose for a patient who has already reached their goal weight and just needs enough GLP-1 activity to keep their hunger (ghrelin) in check without continuing to lose weight.
Some start on Lira because it’s cheaper or easier to manage daily. Once they hit that 28-week "poop out" point, they switch to Tirzepatide or Semaglutide.